XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(Q3)Dec 27, 2024 | (Q2)Sep 27, 2024 | (Q1)Jun 28, 2024 | (FY)Mar 29, 2024 | (Q4)Mar 29, 2024 | (Q3)Dec 29, 2023 | (Q2)Sep 29, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -111.28%-8.18M | -66.73%15.55M | -31.14%34.2M | -5.95%181.72M | -73.16%12.76M | 34.73%72.56M | -15.42%46.73M | 35.87%49.66M | 23.75%193.21M | 26.56%47.55M |
Net income from continuing operations | -120.36%-6.8M | -151.18%-33.61M | -128.93%-17.61M | -18.46%152.89M | -111.41%-7.07M | -48.25%33.4M | 29.66%65.67M | 492.13%60.89M | 56.83%187.49M | 141.74%62.01M |
Operating gains losses | 372.00%68K | --41.32M | --14K | -75.44%70K | 2,700.00%52K | -167.57%-25K | ---- | ---- | 181.66%285K | ---2K |
Depreciation and amortization | -20.16%16.12M | 6.08%16M | 15.31%16.46M | 40.49%71.38M | 54.82%21.83M | 60.53%20.2M | 23.54%15.08M | 19.76%14.27M | 4.70%50.81M | 17.48%14.1M |
Deferred tax | 62.93%-3.75M | 71.39%-2.8M | 40.22%-5M | 53.60%-18.61M | 182.19%9.64M | 15.36%-10.12M | -13.01%-9.77M | -7.43%-8.36M | -635.02%-40.12M | -211.08%-11.73M |
Other non cash items | 275.14%694K | 319.18%306K | 2,197.06%781K | 119.51%527K | 413.33%235K | 640.00%185K | 102.95%73K | 119.32%34K | -42.23%-2.7M | -159.52%-75K |
Change In working capital | -260.13%-28.14M | 50.98%-19.32M | 173.04%27.06M | -69.66%-94.08M | -111.26%-35.19M | 195.79%17.57M | -1,474.47%-39.41M | -106.42%-37.05M | -3.99%-55.45M | 40.38%-16.66M |
-Change in receivables | -238.97%-7.06M | -612.59%-13.72M | 634.19%55.13M | 12.27%-9M | -1.12%-6.44M | 142.48%5.08M | -73.43%2.68M | -415.02%-10.32M | 51.19%-10.26M | 57.21%-6.36M |
-Change in inventory | -270.11%-19.24M | 13.10%-2.85M | 42.80%-15.99M | 78.91%-15.85M | 111.28%4.06M | 151.87%11.31M | 73.68%-3.27M | -471.75%-27.95M | -1,580.83%-75.15M | -366.38%-36.01M |
-Change in prepaid assets | 327.76%14.41M | -125.38%-14.09M | 83.19%-1.72M | -72.94%-40.23M | -393.38%-27.15M | 140.62%3.37M | -272.16%-6.25M | 22.15%-10.2M | -19.60%-23.26M | 27.41%-5.5M |
-Change in payables and accrued expense | -337.72%-12.67M | 137.25%10.64M | -1,147.01%-13.81M | -198.11%-34.23M | -142.49%-4.09M | -113.59%-2.9M | -2,014.58%-28.57M | -75.18%1.32M | 551.33%34.89M | 8,123.93%9.62M |
-Change in other working capital | -606.10%-3.57M | 117.42%695K | -65.98%3.44M | -71.46%5.23M | -107.34%-1.59M | -70.72%705K | -65.29%-3.99M | 409.21%10.1M | 2,880.88%18.33M | 920.75%21.6M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -111.28%-8.18M | -66.73%15.55M | -31.14%34.2M | -5.95%181.72M | -73.16%12.76M | 34.73%72.56M | -15.42%46.73M | 35.87%49.66M | 23.75%193.21M | 26.56%47.55M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 97.00%-13.3M | 60.09%-9.97M | 68.58%-10.98M | -418.29%-516.72M | 53.06%-14.27M | -2,985.25%-442.52M | 38.39%-24.99M | -142.82%-34.94M | -50.44%-99.7M | -88.29%-30.41M |
Net PPE purchase and sale | 60.42%-13.62M | 68.03%-9.97M | 75.56%-10.98M | -56.40%-124.77M | 52.76%-14.27M | -139.83%-34.4M | -49.73%-31.19M | -212.11%-44.91M | -87.56%-79.78M | -113.54%-30.21M |
Net business purchase and sale | ---- | ---- | ---- | -1,948.69%-408.12M | --0 | ---- | ---- | ---- | -36.92%-19.92M | 90.35%-193K |
Net investment purchase and sale | --319K | --0 | --0 | --16.18M | --0 | --0 | --6.2M | --9.97M | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 97.00%-13.3M | 60.09%-9.97M | 68.58%-10.98M | -418.29%-516.72M | 53.06%-14.27M | -2,985.25%-442.52M | 38.39%-24.99M | -142.82%-34.94M | -50.44%-99.7M | -88.29%-30.41M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -112.12%-25.92M | 249.75%7.09M | -447.15%-60.38M | 1,094.49%198.88M | 122.09%730K | 10,296.14%213.92M | 13.32%-4.73M | -20.77%-11.04M | -276.82%-20M | -466.30%-3.3M |
Net issuance payments of debt | -111.32%-25.32M | 4,931.08%193.24M | ---50.15M | 3,017.91%218.84M | ---866K | --223.71M | ---4M | --0 | 0.00%-7.5M | --0 |
Net common stock issuance | ---116K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | --0 | --1.99M | --0 | 30.15%3.64M | 42.30%1.74M | --0 | --0 | --1.9M | -1.34%2.79M | -20.78%1.22M |
Net other financing activities | 95.07%-483K | 74.18%-189K | 20.88%-10.23M | -54.34%-23.6M | 96.91%-140K | -366.83%-9.79M | -256.41%-732K | -41.56%-12.93M | -2,296.71%-15.29M | -165.93%-4.52M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -112.12%-25.92M | 249.75%7.09M | -447.15%-60.38M | 1,094.49%198.88M | 122.09%730K | 10,296.14%213.92M | 13.32%-4.73M | -20.77%-11.04M | -276.82%-20M | -466.30%-3.3M |
Net cash flow | ||||||||||
Beginning cash position | -47.40%199.04M | -49.17%184.18M | -38.07%222.16M | 23.78%358.71M | -34.98%223.74M | 24.78%378.43M | 22.29%362.32M | 23.78%358.71M | 42.15%289.8M | 29.03%344.13M |
Current changes in cash | 69.63%-47.4M | -25.57%12.66M | -1,107.29%-37.16M | -285.17%-136.12M | -105.62%-778K | -517.09%-156.05M | 84.24%17.01M | -71.68%3.69M | -13.06%73.51M | -38.01%13.84M |
Effect of exchange rate changes | -298.67%-2.68M | 344.17%2.2M | -1,030.14%-825K | 90.86%-421K | -207.86%-796K | -60.70%1.35M | 59.47%-901K | 98.89%-73K | -435.47%-4.61M | -4.03%738K |
End cash Position | -33.42%148.96M | -47.40%199.04M | -49.17%184.18M | -38.07%222.16M | -38.07%222.16M | -34.98%223.74M | 24.78%378.43M | 22.29%362.32M | 23.78%358.71M | 23.78%358.71M |
Free cash flow | -157.12%-21.8M | -64.12%5.58M | 388.51%23.22M | -49.80%56.94M | -108.70%-1.51M | -3.42%38.16M | -54.85%15.54M | -78.56%4.75M | 31.61%113.43M | -25.98%17.34M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |